Folate Alpha Targeting: Exciting New Options for Platinum Resistance Ovarian Cancer Patients

Description

Recorded Live: July 21, 2022

Speaker & Presentation Information

Moderator:
Rob Coleman, MD

Panelists:
David O'Malley, MD
Kathleen Moore, MD, MS

Supported in part by

Summary


Availability:	On-Demand


Cost:	FREE

Create Account

Recommended

Phase III MIRASOL (GOG 3045/ENGOT-ov55) Study Results

FREE

Treatment Options for Platinum Resistant Ovarian Cancer

FREE

An Evolving Frontier: Endometrial Cancer Treatment

FREE

Mismatch repair endometrial cancer, what to do at first recurrence and beyond?

FREE

Palliative Care Certificate Program (2023 Update)

FREE

Phase II PICCOLO Trial Results

Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.

FREE

Emerging data in platinum resistance advanced ovarian cancer - Webinar

FREE

International Gynecologic Cancer Society and International Journal of Gynecological Cancer Evidence-Based Medicine for Gynecological Oncology Curriculum (EBM on the GO)

FREE

Immunotherapy and its impact on overall survival in patients with recurrent endometrial cancer

FREE

Newly Opened Phase 3 Study for Low Grade Serous Ovarian Cancer - Webinar

FREE